Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy

Sokolovska,Jelizaveta; Dekante,Alise; Baumane,Larisa; Pahirko,Leonora; Valeinis,Janis; Dislere,Kristine; Rovite,Vita; Pirags,Valdis; Sjakste,Nikolajs

doi:10.3892/br.2020.1288

Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy

Authors:
- Jelizaveta Sokolovska
- Alise Dekante
- Larisa Baumane
- Leonora Pahirko
- Janis Valeinis
- Kristine Dislere
- Vita Rovite
- Valdis Pirags
- Nikolajs Sjakste
View Affiliations

Affiliations: Laboratory for Personalized Medicine, Faculty of Medicine, University of Latvia, LV-1004 Riga, Latvia, Biochemistry Team, Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia, Laboratory for Statistics Research and Data Analysis, Faculty of Physics, Mathematics and Optometry, University of Latvia, LV-1004 Riga, Latvia, Laboratory of Genomics and Bioinformatics, Institute of Biology, University of Latvia, LV-1004 Riga, Latvia, Database of Latvian Population, Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia, Department of Medical Biochemistry, Faculty of Medicine, University of Latvia, LV-1004 Riga, Latvia
Published online on: March 4, 2020 https://doi.org/10.3892/br.2020.1288
Pages: 251-258

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetes leads to reduced nitric oxide bioavailability, resulting in endothelial dysfunction. However, overproduction of nitric oxide due to hyperglycaemia is associated with oxidative stress and tissue damage. The objective of this study was to characterise nitric oxide production (NO) and added nitrite and nitrate (NO2‑+NO3‑) concentration in the blood and urine of patients with and without diabetic nephropathy. A total of 268 patients with type 1 diabetes and 69 healthy subjects were included. Diabetic nephropathy was defined as macroalbuminuria and/or estimated glomerular filtration rate below 60 ml/min/1.73 cm2. NO2‑+NO3‑ concentration was measured by Griess reaction. Production of NO was detected by electron paramagnetic resonance spectroscopy. Blood NO was demonstrated to be higher (P<0.001) and serum NO2‑+NO3‑ was lower (P=0.003) in patients with type 1 diabetes and no nephropathy vs. healthy subjects. However, serum NO2‑+NO3‑ concentration in patients with diabetes and nephropathy did not differ from the levels observed in healthy controls. Urine excretion of NO2‑+NO3‑ was significantly decreased in patients with nephropathy, compared with patients without diabetic kidney disease (P=0.006) and healthy subjects (P=0.010). A significant positive correlation was observed between urine NO2‑+NO3‑ and estimated glomerular filtration rate in patients with type 1 diabetes (P=0.002) and healthy subjects (P=0.008). Estimated glomerular filtration rate, albuminuria and diabetic nephropathy status were significant predictors of the whole blood NO and NO2‑+NO3‑ in serum and urine in patients with type 1 diabetes, as identified by linear regression models. The present study concludes that NO metabolism is impaired by type 1 diabetes and diabetic nephropathy.

View Figures

View References

1	Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ and Buse JB: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 61:2461–2498. 2018.PubMed/NCBI View Article : Google Scholar
2	Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005.PubMed/NCBI View Article : Google Scholar
3	Dellamea BS, Leitão CB, Friedman R and Canani LH: Nitric oxide system and diabetic nephropathy. Diabetol Metab Syndr. 6(17)2014.PubMed/NCBI View Article : Google Scholar
4	Yamagishi S and Matsui T: Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe? Pharmacol Res. 64:187–194. 2011.PubMed/NCBI View Article : Google Scholar
5	Pacher P, Beckman J and Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 87:315–424. 2007.PubMed/NCBI View Article : Google Scholar
6	Tessari P: Nitric oxide in the normal kidney and in patients with diabetic nephropathy. J Nephrol. 28:257–268. 2015.PubMed/NCBI View Article : Google Scholar
7	Ošiņa K, Rostoka E, Sokolovska J, Paramonova N, Bisenieks E, Duburs G, Sjakste N and Sjakste T: 1,4-Dihydropyridine derivatives without Ca²⁺-antagonist activity up-regulate Psma6 mRNA expression in kidneys of intact and diabetic rats. Cell Biochem Funct. 34:3–6. 2016.PubMed/NCBI View Article : Google Scholar
8	Leonova E, Sokolovska J, Boucher JL, Isajevs S, Rostoka E, Baumane L, Sjakste T and Sjakste N: New 1,4-Dihydropyridines down-regulate nitric oxide in animals with streptozotocin-induced diabetes mellitus and protect deoxyribonucleic acid against peroxynitrite action. Basic Clin Pharmacol Toxicol. 119:19–31. 2016.PubMed/NCBI View Article : Google Scholar
9	Zweier JL and Talukder MA: The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 70:181–190. 2006.PubMed/NCBI View Article : Google Scholar
10	Alef MJ, Tzeng E and Zuckerbraun BS: Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia. Nitric Oxide. 26:285–294. 2012.PubMed/NCBI View Article : Google Scholar
11	Chen JY, Ye ZX, Wang XF, Chang J, Yang MW, Zhong HH, Hong FF and Yang SL: Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed Pharmacother. 97:423–428. 2018.PubMed/NCBI View Article : Google Scholar
12	Ceriello A and Testa R: Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care. 32 (Suppl 2):S232–S236. 2009.PubMed/NCBI View Article : Google Scholar
13	Tessari P, Cecchet D, Cosma A, Vettore M, Coracina A, Millioni R, Iori E, Puricelli L, Avogaro A and Vedovato M: Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes. 59:2152–2159. 2010.PubMed/NCBI View Article : Google Scholar
14	Cherney DZ, Reich HN, Jiang S, Har R, Nasrallah R, Hébert RL, Lai V, Scholey JW and Sochett EB: Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 303:R710–R718. 2012.PubMed/NCBI View Article : Google Scholar
15	Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F and Mezzetti A: Increased circulating nitric oxide in young patinets with type 1 diabetes and persistent microalbuminuria: Relation to glomerular hyperfiltration. Diabetes. 49:1258–1263. 2000.PubMed/NCBI View Article : Google Scholar
16	Savino A, Pelliccia P, Schiavone C, Primavera A, Tumini S, Mohn A and Chiarelli F: Serum and urinary nitrites and nitrates and doppler sonography in children with diabetes. Diabetes Care. 29:2676–2681. 2006.PubMed/NCBI View Article : Google Scholar
17	Ma L, Hu L, Feng X and Wang S: Nitrate and nitrite in health and disease. Aging Dis. 9:938–945. 2018.PubMed/NCBI View Article : Google Scholar
18	Bahadoran Z, Ghasemi A, Mirmiran P, Azizi F and Hadaegh F: Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications. Nutr Metab (Lond). 12(16)2015.PubMed/NCBI View Article : Google Scholar
19	Vanin AF: Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems. Biochemistry (Mosc). 63:782–793. 1998.PubMed/NCBI
20	Zhang X: Real time and in vivo monitoring of nitric oxide by electrocehmical sensors-from dream to reality. Front Biosci. 9:3434–3446. 2004.PubMed/NCBI View Article : Google Scholar
21	Sun J, Zhang X, Broderick M and Fein H: Measurement of nitric oxide production in biological systems by using griess reaction assay. Sensors. 3:276–284. 2003.
22	National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 (Suppl 1): S1-S266, 2002.
23	Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T and Coresh J: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612. 2009.PubMed/NCBI View Article : Google Scholar
24	Borisovs V, Ļeonova E, Baumane L, Kalniņa J, Mjagkova N and Sjakste N: Blood levels of nitric oxide and DNA breaks assayed in whole blood and isolated peripheral blood mononucleated cells in patients with multiple sclerosis. Mutat Res. 843:90–94. 2018.PubMed/NCBI View Article : Google Scholar
25	R Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL. http://www.R.project.org/.
26	Bizjak DA, Brinkmann C, Bloch W and Grau M: Increase in red blood cell-nitric oxide synthase dependent nitric oxide production during red blood cell aging in health and disease: A study on age dependent changes of rheologic and enzymatic properties in red blood cells. PLoS One. 10(e0125206)2015.PubMed/NCBI View Article : Google Scholar
27	Cortese-Krott MM and Kelm M: Endothelial nitric oxide synthase in red blood cells: Key to a new erythrocrine function? Redox Biol. 2:251–258. 2014.PubMed/NCBI View Article : Google Scholar
28	Garcia-Bonilla L, Moore JM, Racchumi G, Zhou P, Butler JM, Iadecola C and Anrather J: Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice. J Immunol. 193:2531–2537. 2014.PubMed/NCBI View Article : Google Scholar
29	Gambaryan S and Tsikas D: A review and discussion of platelet nitric oxide and nitric oxide synthase: Do blood platelets produce nitric oxide from l-arginine or nitrite? Amino Acids. 7:1779–1793. 2015.PubMed/NCBI View Article : Google Scholar
30	Saluja R, Saini R, Mitra K, Bajpai VK and Dikshit M: Ultrastructural immunogold localization of nitric oxide synthase isoforms in rat and human eosinophils. Cell Tissue Res. 340:381–388. 2010.PubMed/NCBI View Article : Google Scholar
31	Bogdan C: Nitric oxide synthase in innate and adaptive immunity: An update. Trends Immunol. 36:161–178. 2015.PubMed/NCBI View Article : Google Scholar
32	Tse WY, Williams J, Pall A, Wilkes M, Savage CO and Adu D: Antineutrophil cytoplasm antibody-induced neutrophil nitric oxide production is nitric oxide synthase independent. Kidney Int. 59:593–600. 2001.PubMed/NCBI View Article : Google Scholar
33	Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N and Stefanadis C: The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 10:4–18. 2012.PubMed/NCBI View Article : Google Scholar
34	Miyata S, Noda A, Hara Y, Ueyama J, Kitaichi K, Kondo T and Koike Y: Nitric oxide plasma level as a barometer of endothelial dysfunction in factory workers. Exp Clin Endocrinol Diabetes. 125:684–689. 2017.PubMed/NCBI View Article : Google Scholar
35	Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N and Savli H: Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye (Lond). 16:163–170. 2002.PubMed/NCBI View Article : Google Scholar
36	Hoeldtke RD, Bryner KD and Vandyke K: Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 21:19–28. 2011.PubMed/NCBI View Article : Google Scholar
37	Ceriello A: Nitrotyrosine: New findings as a marker of postprandial oxidative stress. Int J Clin Pract Suppl. 51–58. 2002.PubMed/NCBI
38	Stepanova YI, Kolpakov IY, Zyhalo VM and Boyarsky VG: Correction of endothelial dysfunction in children-residents of radioactively contaminated areas by nitric oxide donator. Probl Radiac Med Radiobiol. 21:336–344. 2016.PubMed/NCBI
39	Norouzirad R, González-Muniesa P and Ghasemi A: Hypoxia in obesity and diabetes: Potential therapeutic effects of hyperoxia and nitrate. Oxid Med Cell Longev. 2017(5350267)2017.PubMed/NCBI View Article : Google Scholar
40	Gumanova NG, Teplova NV, Ryabchenko AU and Denisov EN: Serum nitrate and nitrite levels in patients with hypertension and ischemic stroke depend on diet: A multicenter study. Clin Biochem. 48:29–32. 2015.PubMed/NCBI View Article : Google Scholar
41	Schneider MP, Ott C, Schmidt S, Kistner I, Friedrich S and Schmieder RE: Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patients with type 2 diabetes. Diabetes Care. 36:4071–4075. 2013.PubMed/NCBI View Article : Google Scholar